Devonian Health Group Inc.
DVHGD
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -83.08% | -87.44% | 29.43% | 256.11% | 344.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -83.08% | -87.44% | 29.43% | 256.11% | 344.33% |
| Cost of Revenue | -87.60% | -99.91% | 15.03% | 293.10% | 444.86% |
| Gross Profit | -73.61% | -71.51% | 65.21% | 190.98% | 220.34% |
| SG&A Expenses | -20.55% | -49.36% | 30.01% | 0.71% | 134.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 2.59% | 5.96% | 0.00% | -1.31% | 1.31% |
| Total Operating Expenses | -61.08% | -80.59% | 23.49% | 133.18% | 230.90% |
| Operating Income | -175.58% | -128.38% | 89.85% | 120.18% | 11.66% |
| Income Before Tax | -152.89% | -129.14% | -1,126.72% | 116.43% | 16.37% |
| Income Tax Expenses | -- | -102.19% | -- | -- | -- |
| Earnings from Continuing Operations | -152.89% | -149.82% | -610.75% | 82.12% | 16.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -152.89% | -149.82% | -610.75% | 82.12% | 16.37% |
| EBIT | -175.58% | -128.38% | 89.85% | 120.18% | 11.66% |
| EBITDA | -218.95% | -124.76% | 131.55% | 130.47% | 10.65% |
| EPS Basic | -126.01% | -149.84% | -607.34% | 82.34% | 17.63% |
| Normalized Basic EPS | -126.07% | -129.14% | 109.00% | 116.24% | 17.66% |
| EPS Diluted | -126.01% | -149.84% | -607.34% | 85.40% | 18.56% |
| Normalized Diluted EPS | -126.07% | -129.14% | 109.20% | 116.24% | 17.66% |
| Average Basic Shares Outstanding | 11.87% | -0.01% | 0.47% | 1.28% | 1.55% |
| Average Diluted Shares Outstanding | 11.87% | -0.01% | -0.73% | 1.28% | 1.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |